Christina Cristiano - Feb 26, 2025 Form 4 Insider Report for Crane NXT, Co. (CXT)

Role
SVP, Chief Financial Officer
Signature
/s/ Paul G. Igoe, Attorney-in-Fact
Stock symbol
CXT
Transactions as of
Feb 26, 2025
Transactions value $
-$29,283
Form type
4
Date filed
2/28/2025, 04:17 PM
Previous filing
Feb 10, 2025
Next filing
Apr 22, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CXT COMMON STOCK Options Exercise $0 +1.02K +17.83% $0.00 6.76K Feb 28, 2025 Direct F1
transaction CXT COMMON STOCK Tax liability -$29.3K -523 -7.73% $55.99 6.24K Feb 28, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CXT Restricted Share Unit Award $0 +4.8K +33.35% $0.00 19.2K Feb 26, 2025 COMMON STOCK 4.8K Direct F2, F3
transaction CXT 2025 Performance-Based Restricted Share Unit Award $0 +9.6K $0.00 9.6K Feb 26, 2025 COMMON STOCK 9.6K Direct F4, F5
transaction CXT Employee Stock Option (Right to Buy) Award $0 +11.8K $0.00 11.8K Feb 26, 2025 COMMON STOCK 11.8K $57.28 Direct F6
transaction CXT Restricted Share Unit Options Exercise $0 -1.02K -5.33% $0.00 18.2K Feb 28, 2025 COMMON STOCK 1.02K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of 1,023 previously reported Restricted Share Units.
F2 Restricted Share Units convert into common stock on a one-for-one basis.
F3 Restricted Share Units vest 25% per year over four years beginning on the first anniversary of the date of grant.
F4 Each 2025 Performance-Based Restricted Share Unit (RSU) represents a contingent right to receive a number of shares of issuer common stock between 0 and 2.00.
F5 2025 Performance-Based RSUs vest on December 31, 2027, if issuer's common stock achieves certain performance criteria for each fiscal year over the three years ending December 31, 2027, and contingent on continued employment with issuer, subject to certain exceptions.
F6 Options become exercisable 25% per year over four years beginning on the first anniversary of the date of grant.